Wednesday, February 19, 2014 12:41:47 PM
Problem is growth in North America not the global market. Ever heard of implosion, it's coming to Denver. Core values of the company out the window, now they spread their talent thin and cheap at the facility level(that would be the clinical staff). KT CAN'T do what he did with DaVita in North America since 1999. If rapid global growth detracts from the largest market for dialysis, (USA) then KT is just running as fast as he can from the truth about ACA and dialysis reimbursement. Bottom line, KT forgot core values, his TEAMATES, and they do the clinical work and take less MONEY than NON corporate health care. That means USA TEAMATES and core values will disintegrate once the shift is completely to a global market. Ask how many bonuses clinical staff get for reaching metric goals. Those bonus programs were designed to get the clinical staff to meet these goals and prove DaVita was the provider of choice(a core value by the way). Those bonuses are nearly gone unless rolled out in unison by corporate. BUT the bonuses for middle management are big. The administrator has a plethora of bonus programs to choose from. Metric bonuses, employee retention bonuses, special retreats and training. Then there's the regional directors who get bonuses for herding their administrators into the right numbers. SOOO thanks KT for that phenomenol performance for 15 years, uhh your belief in your teamates and company core values WERE great. You won't find friends on the other side of the pond as you did here.
Recent DVA News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/18/2026 08:11:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/18/2026 08:11:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/18/2026 08:11:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/18/2026 08:11:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/18/2026 08:11:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/18/2026 08:11:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/18/2026 08:11:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/18/2026 08:11:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/18/2026 08:08:52 PM
- DaVita Sets Bold 2030 Community Care Commitments After Exceeding Prior Five-Year ESG Goals • PR Newswire (US) • 05/18/2026 07:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/15/2026 07:12:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2026 08:10:23 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/11/2026 09:40:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/11/2026 08:05:59 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/07/2026 08:43:29 PM
- DaVita Inc. to Participate in the BofA Securities 2026 Health Care Conference • PR Newswire (US) • 05/06/2026 10:01:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/06/2026 08:03:39 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/05/2026 09:03:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/05/2026 08:09:12 PM
- DaVita Inc. 1st Quarter 2026 Results • PR Newswire (US) • 05/05/2026 08:05:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/22/2026 08:56:57 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/22/2026 08:48:12 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/22/2026 08:30:45 PM
- DaVita Inc. Schedules 1st Quarter 2026 Investor Conference Call • PR Newswire (US) • 04/20/2026 06:06:00 PM
- DaVita Highlights Continued Progress in Value-Based Kidney Care as CKCC Results Show Year-Over-Year Improvement • PR Newswire (US) • 03/18/2026 07:00:00 PM
